Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1524-2022Class II

ARIES SARS-CoV-2 Assay

Luminex Corporation / initiated 2022-07-14 / Open, Classified / root cause: manufacturing process

Luminex Corporation began a recall of ARIES SARS-CoV-2 Assay on . FDA classified it as Class II and gives the reason as "SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1524-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Luminex Corporation
Product
ARIES SARS-CoV-2 Assay
Product code
QJR Reagents, 2019-Novel Coronavirus Nucleic Acid
Reason for recall
SARS-CoV-2 assay that detects SARS-CoV-2 ORF1ab and N genes may not detect the ORF1ab gene. A positive results if either SARS-CoV-2 genes is detected, but If both genes are mistakenly not detected, a false negative result would be generated.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 7/14/22 recall notices were emailed to consignees who were asked to review any results from the affected lot to confirm the validity of the results. In addition, all remaining cassettes from this lot should be discarded. Customers with questions are encouraged to contact the firm at: 1-877-785-2323 (U.S. and Canada), +1-512-381-4397 (Outside U.S. and Canada), [email protected]
Quantity in commerce
257
Distribution
U.S. Nationwide distribution in the states of NE, TX, MS, TN, KY, ME, CA.
Product codes and lots
Lot: AB4042A

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1524-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1524-2022Class IIOngoingVoluntary: Firm initiated